Avanza Fonder AB Has $6 Million Stake in Synopsys, Inc. $SNPS

Avanza Fonder AB increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 23.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,157 shares of the semiconductor company’s stock after purchasing an additional 2,299 shares during the period. Avanza Fonder AB’s holdings in Synopsys were worth $5,998,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in Synopsys by 1.6% during the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock worth $7,721,363,000 after acquiring an additional 231,014 shares during the period. State Street Corp increased its stake in Synopsys by 1.2% during the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after acquiring an additional 85,662 shares during the period. Geode Capital Management LLC lifted its position in shares of Synopsys by 1.5% during the 2nd quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock valued at $1,810,214,000 after acquiring an additional 51,043 shares during the period. Ameriprise Financial Inc. grew its holdings in shares of Synopsys by 29.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after purchasing an additional 585,494 shares in the last quarter. Finally, Alliancebernstein L.P. increased its position in shares of Synopsys by 10.9% in the second quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock worth $980,757,000 after purchasing an additional 187,790 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.

Synopsys Trading Up 0.0%

NASDAQ SNPS opened at $475.50 on Friday. The firm has a market capitalization of $90.97 billion, a PE ratio of 59.51, a price-to-earnings-growth ratio of 3.96 and a beta of 1.16. The business’s 50-day moving average price is $436.99 and its two-hundred day moving average price is $503.73. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The firm’s quarterly revenue was up 37.8% on a year-over-year basis. During the same period in the previous year, the firm earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.

Analysts Set New Price Targets

Several research firms have commented on SNPS. Piper Sandler decreased their target price on shares of Synopsys from $630.00 to $602.00 and set an “overweight” rating on the stock in a report on Thursday, December 11th. Stifel Nicolaus decreased their target price on Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their target price for the stock from $525.00 to $500.00 in a report on Monday, December 8th. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Finally, Baird R W cut Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 10th. Eleven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $562.13.

Insider Buying and Selling at Synopsys

In other news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.62% of the company’s stock.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.